Images List Premium Download Classic

Prophylactic

Prophylactic-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Anti-zika virus antibodies and methods of use
Regeneron Pharmaceuticals, Inc.
January 18, 2018 - N°20180016324

The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to zikv glycoproteins, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing zikv activity, thus providing a means of treating or preventing zikv infection in humans. In some embodiments, the invention provides for use of one or ...
NEW Therapeutic and prophylactic methods, uses and compositions comprising anexin a5
Annexin Pharmaceuticals Ab
January 18, 2018 - N°20180015142

The present invention provides a method for the prevention and/or reduction of peri- or postoperative complications following surgical intervention, such as complications following vascular surgery, especially peripheral vascular surgery, comprising administering a therapeutically effective amount of annexin a5 or a functional analogue or variant thereof to a patient in need of such treatment. Also provided is a pharmaceutical composition ...
NEW Methods for on demand pre-exposure prophylactic treatment of hiv infection
Commissariat À L'Énergie Atomique
January 18, 2018 - N°20180015111

The present invention relates to methods for on demand pre-exposure prophylactic treatment of hiv infection. In particular, the present invention relates to a method for on demand pre-exposure prophylactic treatment of a subject at substantial risk for hiv infection comprising administering orally the subject with a combination of a therapeutically effective amount of emtricitabine and tenofovir prior and after to ...
NEW Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof
University Of Technology, Sydney
January 11, 2018 - N°20180010104

The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a ...
Unit aerosol doses for anticoagulation
The Regents Of The University Of California
January 11, 2018 - N°20180008540

Disclosed herein are methods for prophylactic treatment of acute coronary syndrome (acs) comprising administering, by inhalation, an effective amount of a pharmaceutical composition comprising at least one anticoagulant or antiplatelet agent to a subject in need thereof, wherein the anticoagulant or antiplatelet agent first enters the heart via the left atrium.
Discreet emergency hygiene kit
January 11, 2018 - N°20180008489

A discreet packaged sterile hygiene kit for the unexpected menstrual cycle and safe sex. Kit is comprised such as at least sterile scented underwear, or leggings, and either one in addition to the undergarments/leggings and at least tampons, sanitary pads, panty liners, and at least sterile wipes, and at least prophylactic birth control/safe sex. Packaged uniquely in a ...
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Long-acting polymeric delivery systems
Heron Therapeutics, Inc.
January 04, 2018 - N°20180000947

Compositions comprised of a delivery vehicle or delivery system and an active agent dispersed within the delivery vehicle or system, wherein the delivery vehicle or system contains a polyorthoester polymer and a polar aprotic solvent. Also disclosed are low viscosity delivery systems for administration of active agents. The low viscosity delivery systems have a polyorthoester polymer, a polar aprotic solvent ...
Antioxidant agent, and antioxidant cosmetic and uv care cosmetic
Ezaki Glico Co., Ltd.
January 04, 2018 - N°20180000856

The present invention provides an antioxidant, an ros inhibitor, an antioxidant enzyme production promoter, an antioxidant cosmetic, a uv care cosmetic, a prophylactic or therapeutic agent for gastrointestinal tract inflammation, and an antioxidant food or beverage, each containing an enzymatically synthesized glycogen (esg) or an α-amylase digest (rg) thereof, as well as use for enhancing an antioxidative effect ...
Agent for preventing and/or treating amyotrophic lateral sclerosis
Kyoto University
January 04, 2018 - N°20180000771

The present invention provides a prophylactic and/or therapeutic agent for amyotrophic lateral sclerosis (als), which contains one or more kinase inhibitors selected from the group consisting of an epithelial cell growth factor receptor (egfr) inhibitor, a fibroblast growth factor receptor (fgfr) inhibitor, an aurorakinase inhibitor, a protein kinase a (pka) inhibitor, a protein kinase c (pkc) inhibitor, an mek ...
Novel tilapia virus and uses thereof
Kimron Veterinary Institute
December 21, 2017 - N°20170360918

The invention is directed to isolated tilapia lake virus or tilv, and isolated nucleic acids sequences and polypeptides thereof. The invention also relates to probes and primers, and to antibodies against antigens from tilv, and use of these reagents for detecting the presence or absence of tilv in an animal. The invention also relates to irnas which target nucleic acid ...
Tumor antigen peptide
Sumitomo Dainippon Pharma Co., Ltd.
December 21, 2017 - N°20170360911

The purpose of the present invention is to provide: a detection agent for specifically detecting a cancer stem cell; a tumor antigen peptide specifically presented by cancer stem cells; a medicinal composition useful in preventing and/or treating cancer, said medicinal composition comprising the aforementioned tumor antigen peptide as an active ingredient; a method for screening the tumor antigen peptide; ...
Methods for treating and preventing cardiomyopathy
University Of Washington
December 21, 2017 - N°20170360886

Methods for treating patients having a cardiomyopathy are provided. Additionally, methods for prophylactically treating patients at risk of developing a cardiomyopathy are provided. Methods for treating patients having, or at risk of developing, a cardiomyopathy may comprise administering a fusion protein including a tafazzin peptide and a cellular permeability peptide to the patient. Further, the tafazzin peptide may be coupled ...
Non-anticoagulant sulfated or sulfonated polysaccharides
Baxalta Gmbh
December 21, 2017 - N°20170360823

The present invention provides non-anticoagulant sulfated or sulfonated polysaccharides (nasps), which accelerate the blood clotting process. Also provided are pharmaceutical formulations comprising a nasp of the invention in conjunction with a pharmaceutically acceptable excipient and, in various embodiments, these formulations are unit dosage formulations. The invention provides a nasp formulation, which is orally bioavailable. Also provided are methods for utilizing ...
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Use of simple amino acids to form porous particles
Civitas Therapeutics, Inc.
December 14, 2017 - N°20170354602

Particles having a tap density of less than 0. 4 g/cm3 include a hydrophobic amino acid or salt thereof and a therapeutic, prophylactic or diagnostic agent or any combination thereof. Preferred particles include a phospholipid, have a median geometric diameter between about 5 and about 30 microns and an aerodynamic diameter between about 1 and about 5 microns. The particles can be formed by spray-drying ...
Prevention and treatment of synucleinopathic and amyloidogenic disease
The Regents Of The University Of California
December 07, 2017 - N°20170349651

The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the lewy body. The methods are particularly useful prophylactic and therapeutic treatment of parkinson's disease.
Dihydroindolizinone derivative
Ono Pharmaceutical Co., Ltd.
December 07, 2017 - N°20170349580

A compound represented by general formula (i) (wherein all symbols are as defined in the description) or a salt, solvate, n-oxide form or prodrug thereof is a potent fxia inhibitor, has excellent oral absorption properties and kinetics in blood, can exert a potent anti-coagulation activity over a long period of time after being administered orally, and has a discrepancy between ...
System for improving fluid drainage
December 07, 2017 - N°20170348475

A low-cost and simple-to-use system and method to facilitate a prophylactic pleural lavage protocol at the time of thoracostomy tube placement for traumatic hemothorax in order to reduce the need for secondary intervention for the management of retained hemothorax. The invention may be used in conjunction with existing chest tubes and be administered at the time of initial chest tube ...
Compositions and method of use of a-type procyanidins
Mars, Incorporated
December 07, 2017 - N°20170348339

The invention relates to compositions, such as pharmaceuticals, foods, food additives, or dietary supplements, containing a-type procyanidins, and methods of use thereof, for prophylactic or therapeutic treatment of a human or a veterinary animal to treat or prevent no-responsive health conditions, treat hypertension, cardiovascular disease, coronary artery disease and/or vascular circulation disorders, prevent or reduce the risk of heart ...
Nanobodies against tumor necrosis factor-alpha
Ablynx N.v.
November 30, 2017 - N°20170342146

The present invention relates to improved nanobodies™ against tumor necrosis factor-alpha (tnf-alpha), as well as to polypeptides comprising or essentially consisting of one or more of such nanobodies. The invention also relates to nucleic acids encoding such nanobodies and polypeptides; to methods for preparing such nanobodies and polypeptides; to host cells expressing or capable of expressing such nanobodies or ...
Rsv g protein specific antibodies
Aimm Therapeutics B.v.
November 30, 2017 - N°20170342134

The invention relates to human isolated, synthetic or recombinant antibodies or functional parts thereof, specific for the rsv g protein. Antibodies specific for the rsv g protein are particularly suitable for counteracting rsv and symptoms, such as inflammation, resulting from an rsv infection. The invention further relates to the use of such rsv g-specific antibodies for diagnosis of an rsv ...
Novel aryl-cyanoguanidine compounds
Bayer Pharma Aktiengesellschaft
November 30, 2017 - N°20170342034

The present invention relates to protein-lysine n-methyltransferase smyd2 (set and mynd domain-containing protein 2) inhibitors, in particular smyd2-inhibitory substituted cyanoguanidine-pyrazolines of general formula (i) wherein r1, r2, r3, r4, r5, x and r have the meaning as described and defined herein, as well as to pharmaceutical compositions comprising compounds according to the invention and to their prophylactic and therapeutic use ...
Loading